Page 31 - 《中国药房》2024年8期
P. 31

叶酸修饰的粉防己碱壳聚糖-硬脂酸纳米胶束的制备、表征及体

          外抗炎活性考察
                                   Δ


                *
                                                #
          薛 飞 ,杨 岚,常金花,刘 沛,王汝兴(承德医学院中药研究所/河北省中药研究与开发重点实验室,河北
          承德 067000)

          中图分类号  R943;R965      文献标志码  A      文章编号  1001-0408(2024)08-0925-06
          DOI  10.6039/j.issn.1001-0408.2024.08.05


          摘  要  目的  制备叶酸(FA)修饰的粉防己碱(TET)壳聚糖(CS)-硬脂酸(SA)纳米胶束(简称“FA-CS-SA/TET纳米胶束”),并进
          行表征和体外抗炎活性考察。方法  采用超声法制备FA-CS-SA/TET纳米胶束,以包封率(EE)、载药量(DL)、粒径的综合评分为
          评价指标,FA-CS-SA与TET质量比、超声功率和超声次数为考察因素,根据正交实验确定最优制备工艺并验证;对以最优工艺制
          备的FA-CS-SA/TET纳米胶束进行表征,并考察其体外释放性能。以RAW264.7细胞为实验对象,考察其体外抗炎活性。结果  最
          优制备工艺为 FA-CS-SA 与 TET 质量比 2∶1,超声功率 200 W,超声 200 次。以最优工艺制备的 FA-CS-SA/TET 纳米胶束的 EE 为
         (98.86±0.30)%,DL 为(28.57±0.34)%,平均粒径为(227.0±9.4)nm,多分散性指数为 0.42±0.04,Zeta电位为(12.6±2.3)mV;该
          纳米胶束呈类圆形且分布均匀,其在0.5%十二烷基硫酸钠溶液中释放较快,72 h内的累积释放度为(79.49±3.43)%,且其抗炎作
          用强于 TET 原料药。结论  本研究成功制备了 FA-CS-SA/TET 纳米胶束,其载药性能良好,粒径均匀,且具有较好的体外抗炎
          活性。
          关键词  粉防己碱;纳米胶束;制备工艺;表征;抗炎活性;释放度

          Preparation,  characterization  and  in  vitro anti-inflammatory  activity of  tetrandrine-loaded  chitosan-stearic
          acid nano micelles modified with folic acid
          XUE Fei,YANG Lan,CHANG Jinhua,LIU Pei,WANG Ruxing(Institute of Chinese Materia Medica of Chengde

          Medical University/Hebei Provincial Key Laboratory of Research and Development for Chinese Materia Medica,
          Hebei Chengde 067000, China)

          ABSTRACT   OBJECTIVE  To  prepare  tetrandrine (TET)-loaded  chitosan(CS)-stearic  acid (SA)  nano  micelles  modified  with
          folic acid (FA) (FA-CS-SA/TET nano micelles), characterize them and study the anti-inflammatory effect in vitro. METHODS FA-
          CS-SA/TET  nano  micelles  were  prepared  by  ultrasonic  method;  the  preparation  technology  was  optimized  by  orthogonal  test  and
          validation test was also performed with the mass ratio of FA-CS-SA to TET, ultrasound power and ultrasound times as the factors,
          using the comprehensive score of entrapment efficiency (EE), drug loading (DL) and particle size as evaluation index. FA-CS-SA/
          TET nano micelles prepared by the optimal technology were characterized, and their release performance in vitro was investigated.
          RAW264.7  cells  were  used  as  subjects  to  investigate  their  anti-inflammatory  activity  in  vitro.  RESULTS  The  optimal  preparation
          technology included that the mass ratio of FA-CS-SA to TET was 2∶1, ultrasonic power was 200 W, and the ultrasonic frequency
          was 200 times. The parameters of FA-CS-SA/TET nano micelles prepared by optimized technology included that EE was (98.86±
          0.30)%, DL was (28.57±0.34)%, the average particle size was (227.0±9.4) nm, polydispersity index was 0.42±0.04, and the
          Zeta  potential  was(12.6±2.3)mV,  respectively.  The  nano  micelles  were  uniform  in  appearance  and  round  in  shape.  The  nano
          micelles  were  released  quickly  in  0.5%  sodium  dodecyl  sulfate  solution,  with  a  cumulative  release  rate  of (79.49±3.43)%  within
          72  hours,  and  its  anti-inflammatory  effect  was  stronger  than  that  of  TET  raw  materials.  CONCLUSIONS  FA-CS-SA/TET  nano
                                                             micelles  are  prepared  successfully  in  the  study,  with  good
             Δ 基金项目 河北省自然科学基金项目(No.H2022406073);河北
          省高等学校科学技术研究重点项目(No.ZD2021004);承德医学院高               drug  loading  performance,  uniform  particle  size,  and  good  in
          层次人才科研启动基金项目(No.201705)                            vitro anti-inflammatory activity.
             *第一作者 硕士研究生。研究方向:药物新剂型。E-mail:                  KEYWORDS     tetrandrine; nano micelles; preparation techno-
          741376718@qq.com
                                                             logy; characterization; anti-inflammatory activity; release rate
             # 通信作者 教授,硕士生导师,博士。研究方向:药物新剂型。E-
          mail:wangru1973@sina.com


          中国药房  2024年第35卷第8期                                                 China Pharmacy  2024 Vol. 35  No. 8    · 925 ·
   26   27   28   29   30   31   32   33   34   35   36